MarketLens
Sign Up

Why is Jazz Pharmaceuticals' CBD Drug a Blockbuster Success

8 months ago
SHARE THIS ON:

Why is Jazz Pharmaceuticals' CBD Drug a Blockbuster Success

Exclusive Content for Pro Members

Pro members only. Upgrade to access this article, premium analysis, and stock recommendations.

SHARE THIS ON:

Related Articles

Category

You may also like

Stock News•1 months ago

Endovia Health Sciences Closes Initial Funding to Accelerate CannEpil® Development Amid Growing Federal Support for Botanical Drug Pathways

Endovia Health Sciences closed an initial funding round to accelerate CannEpil® development, as FDA and Congress increase focus on regulated botanical drug pathways. The amount was not disclosed.
News•2 months ago

Why the Drugmaker Behind a Pancreatic Cancer Breakthrough Stayed Independent

Revolution Medicines stayed independent despite takeover interest, and its bet paid off with FDA approval of its pancreatic cancer pill this week, validating its standalone strategy.
Stock News•3 months ago

Is JAZZ Still the Best Cannabis Stock After Federal Rescheduling?

Jazz Pharmaceuticals offers medical cannabis exposure via its FDA-approved CBD drug Epidiolex, paired with a diversified portfolio. The stock's appeal hinges on pipeline execution amid federal resched...

Breaking News

View All →

Top Headlines

View More →
Stock News•1 hour ago

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Alphabet Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GOOGL, GOOG

Stock News•2 hours ago

Stock Market Today, Nov. 4: Amazon Jumps 6% From New Perspective on AWS Growth and AI Strategy Following Election Results

Stock News•2 hours ago

Apple (AAPL)) Price Forecast: Record High Follows Dramatic Reversal

Stock News•2 hours ago

Apple cements its status as tech's biggest heavyweight with the stock's best day in over a year

Stock News•3 hours ago

Here's What a $1,000 Investment in AMD Could Be Worth by 2030